NO20020222L - Oralt aktive androgener - Google Patents

Oralt aktive androgener

Info

Publication number
NO20020222L
NO20020222L NO20020222A NO20020222A NO20020222L NO 20020222 L NO20020222 L NO 20020222L NO 20020222 A NO20020222 A NO 20020222A NO 20020222 A NO20020222 A NO 20020222A NO 20020222 L NO20020222 L NO 20020222L
Authority
NO
Norway
Prior art keywords
orally active
active androgens
androgens
orally
active
Prior art date
Application number
NO20020222A
Other languages
English (en)
Norwegian (no)
Other versions
NO20020222D0 (no
Inventor
Hubert Jan Jozef Loozen
Dirk Leysen
Jaap Van Der Louw
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO20020222D0 publication Critical patent/NO20020222D0/no
Publication of NO20020222L publication Critical patent/NO20020222L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074—Esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20020222A 1999-07-16 2002-01-15 Oralt aktive androgener NO20020222L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99202348 1999-07-16
PCT/EP2000/006544 WO2001005806A1 (en) 1999-07-16 2000-07-10 Orally active androgens

Publications (2)

Publication Number Publication Date
NO20020222D0 NO20020222D0 (no) 2002-01-15
NO20020222L true NO20020222L (no) 2002-01-25

Family

ID=8240463

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020222A NO20020222L (no) 1999-07-16 2002-01-15 Oralt aktive androgener

Country Status (28)

Country Link
US (3) US6313108B1 (de)
EP (1) EP1203011B1 (de)
JP (1) JP2003505394A (de)
KR (1) KR20020092890A (de)
CN (1) CN1360589A (de)
AR (1) AR024746A1 (de)
AT (1) ATE257159T1 (de)
AU (1) AU770412B2 (de)
BR (1) BR0012489A (de)
CA (1) CA2379223A1 (de)
CO (1) CO5200765A1 (de)
CZ (1) CZ2002192A3 (de)
DE (1) DE60007530T2 (de)
ES (1) ES2213596T3 (de)
HK (1) HK1043797A1 (de)
HU (1) HUP0201952A3 (de)
IL (1) IL147332A0 (de)
MX (1) MXPA02000601A (de)
NO (1) NO20020222L (de)
NZ (1) NZ516525A (de)
PE (1) PE20010330A1 (de)
PL (1) PL353007A1 (de)
RU (1) RU2002103883A (de)
SK (1) SK712002A3 (de)
TR (1) TR200200076T2 (de)
TW (1) TW548277B (de)
WO (1) WO2001005806A1 (de)
ZA (1) ZA200200106B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1212345B1 (de) * 1999-04-06 2003-08-06 Akzo Nobel N.V. Oral wirksame 7-alpha-alkyl androgene
EP1272196B1 (de) * 2000-03-31 2006-08-02 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Verfahren zur herstellung von den trans-4-n-butylcyclohexanoicsaüre- und undecanoicsaüreestern von (7-alpha,11-beta)-dimethyl-17 beta -hydroxy-4-estren-3-one und deren medizynische anwendung
US20030069215A1 (en) * 2001-03-30 2003-04-10 The Government Of The United States Of America, Methods of making and using 7a,11b-dimethyl-17b-hydroxy-4-estren-3-one 17b-trans-4-n-butylcyclohexane carboxylate and 7a,11b-dimethyl-17b-hydroxyestr-4-en-3-one 17-undecanoate
ATE294812T1 (de) * 2000-07-28 2005-05-15 Akzo Nobel Nv 16alpha-methyl oder ethyl substituierte oestrogene
DK1379253T3 (da) * 2001-03-30 2006-06-26 Us Gov Health & Human Serv Fremgangsmåde til fremstilling og anvendelse af farmaceutiske formuleringer omfattende 7alfa, 11beta-dimethyl-17beta-hydroxyestra-4, 14-dien-3-on og 17-estere heraf
US20050090476A1 (en) * 2002-01-21 2005-04-28 Arnoldus Maria Van Buggenum Patrick Process for the preparation of 7alpha-methylsteroids
GB0304927D0 (en) * 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
PE20050677A1 (es) 2003-12-22 2005-10-04 Akzo Nobel Nv Esteroides con perfil androgenico y progestagenico mixto
UA89964C2 (ru) 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
CN102227441A (zh) * 2008-10-15 2011-10-26 斯索恩有限公司 制备氟维司群的方法和中间体
SG195118A1 (en) 2011-06-01 2013-12-30 Estetra S A Process for the production of estetrol intermediates
PT2714712T (pt) * 2011-06-01 2016-11-08 Estetra Sprl Processo para a produção de intermediários de estetrol
EP2383279A1 (de) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Herstellungsverfahren für Esterol
RS55231B1 (sr) * 2011-10-07 2017-02-28 Estetra Sprl Postupak proizvodnje estetrola
WO2015181116A1 (en) 2014-05-26 2015-12-03 Crystal Pharma, S.A.U. Process and intermediades for the preparation of 7-alkylated steroids
LT3310346T (lt) 2015-06-18 2021-06-10 Estetra Sprl Burnoje disperguojama tabletė, turinti estetrolio
CR20180042A (es) 2015-06-18 2018-05-03 Mithra Pharmaceuticals S A Unidad de dosificación orodispersable que contiene un componente estetrol.
DK3701944T3 (da) 2015-06-18 2022-03-14 Estetra Srl Oro-dispergerbar doseringsenhed indeholdende en estetrolkomponent
LT3310345T (lt) 2015-06-18 2021-06-25 Estetra Sprl Burnoje disperguojama tabletė, turinti estetrolio
KR102712911B1 (ko) 2016-08-05 2024-10-04 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 월경통 및 생리통의 관리방법
JP7003144B2 (ja) * 2017-02-23 2022-02-10 シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレイテッド 化学発光アンドロステンジオンコンジュゲート
CN111989105B (zh) 2018-04-19 2024-07-19 埃斯特拉私人有限责任公司 化合物以及它们在缓解绝经相关症状中的用途
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA712312B (en) * 1970-04-28 1972-01-26 Ochsner Med Found Alton 4,14-estradiene compounds

Also Published As

Publication number Publication date
WO2001005806A1 (en) 2001-01-25
ZA200200106B (en) 2003-06-25
US6780854B2 (en) 2004-08-24
US6313108B1 (en) 2001-11-06
MXPA02000601A (es) 2002-07-30
US6541465B2 (en) 2003-04-01
DE60007530D1 (de) 2004-02-05
JP2003505394A (ja) 2003-02-12
NZ516525A (en) 2003-06-30
US20030087886A1 (en) 2003-05-08
IL147332A0 (en) 2002-08-14
CO5200765A1 (es) 2002-09-27
HUP0201952A3 (en) 2003-10-28
EP1203011B1 (de) 2004-01-02
CZ2002192A3 (cs) 2002-06-12
RU2002103883A (ru) 2004-02-27
TR200200076T2 (tr) 2002-04-22
PE20010330A1 (es) 2001-03-22
SK712002A3 (en) 2002-06-04
CN1360589A (zh) 2002-07-24
DE60007530T2 (de) 2004-12-23
PL353007A1 (en) 2003-09-22
AR024746A1 (es) 2002-10-23
BR0012489A (pt) 2002-04-02
KR20020092890A (ko) 2002-12-12
TW548277B (en) 2003-08-21
ATE257159T1 (de) 2004-01-15
NO20020222D0 (no) 2002-01-15
CA2379223A1 (en) 2001-01-25
AU6562900A (en) 2001-02-05
AU770412B2 (en) 2004-02-19
HUP0201952A2 (en) 2002-10-28
ES2213596T3 (es) 2004-09-01
EP1203011A1 (de) 2002-05-08
HK1043797A1 (zh) 2002-09-27
US20020022609A1 (en) 2002-02-21

Similar Documents

Publication Publication Date Title
NO20020222D0 (no) Oralt aktive androgener
PT1220856E (pt) Compostos farmaceuticamente activos
IS5568A (is) Lyfjafræðilega virkt morfólínól
DK1181017T3 (da) Metalloproteaseinhibitorer
NO2010019I2 (no) 6-per-deoksy-6-per-(2-karboksetyl)tio-y-cyklodextrin
FI4231U1 (fi) Kotelo
DE60035580D1 (de) Halbleiter
DE60043730D1 (de) Arylsulfonamid-substituierte hydroxamsäure-derivate
DE60032425D1 (de) Ätzvorrichtung
DK1237904T3 (da) 14,15-beta-methylensubstituerede androgener
DE60039349D1 (de) Elektrochemischer kondensator
FI990633L (fi) Pätkätela
DE59902159D1 (de) Aktiver mikromischer
DK1218127T3 (da) Støbevalse
DE60018144D1 (de) Wälzelement
DE60010809D1 (de) Entwicklungsgerät
ITMI991742A0 (it) Bisplatino complessi attivi per via orale
DE50012367D1 (de) Abrollmaschine
ZA200204604B (en) Saccharin derivatives as orally active elastase inhibitors.
ID27139A (id) Bertukol kusmargono
DE60004561D1 (de) Aktive baugruppe
DE60030353D1 (de) Kassette
SE9901854D0 (sv) New pharmaceutically active compounds
IS8740A (is) Lyfjafræðilega virkt morfólínól
SE0000645D0 (sv) New pharmaceutically active compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application